Caplight Directory>Companies>Generare-preview>Generare


Generare

Generare

Private
ParisHealthcare & Life Scienceshttps://generare.bio

Last Round

Series A

Apr 2, 2026

Total Funding Raised

$28.49M

Company Overview

Generare is a biotechnology company that has developed a data-driven discovery platform to identify novel bioactive molecules from microbes for applications in medicine and other industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

natural product discoverydrug discovery platformsynthetic biologymicrobial genomicsAI drug discoverycomputational biologyhigh-throughput screeningshotgun cloningfunctional metagenomicsbioprospectinggenome miningbioactive compoundspharma partnershipsbiosynthetic gene clustersanti-infectivesagricultural biotechcosmetic ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Generare Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Generare Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 2, 2026
SeedOct 8, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Guillaume Vandenesch

CEO Co-founder

Founding Team

Generare Investors

Notable investors and investment history

InvestorRounds
Saras CapitalSeed
AlvenSeries A
SynBioVenSeed
DaphniSeries A
Galion.exeSeries A, Seed
VIVES PartnersSeries A, Seed
Better AngleSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    $23M round completed.

  • Oct 8, 2024

    $5.5M raised in Seed round.

View all signals

Generare Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Generare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Generare's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range30
Year Founded2023
Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.